Latest News

FREELINE THERAPEUTICS APPOINTS ANNE PRENER AS CHIEF EXECUTIVE OFFICER

10th Jul 2017 By admin

Freeline Therapeutics (“Freeline”), a biopharmaceutical company focused on the development of curative gene therapies for bleeding and other debilitating disorders, today announced that Anne Prener has been appointed Chief...

More >

Freeline Therapeutics’ Founder and Chief Scientific Officer is honoured by the European Society for…

21st Oct 2016 By admin

London, 21 October 2016 – Freeline Therapeutics (“Freeline”), a biopharmaceutical company focused on the development of curative gene therapies for bleeding and other debilitating disorders, today announced that The...

More >

Freeline Therapeutics acquires Munich-based manufacturing technology platform and has appointed Dr Markus Hörer as…

18th Apr 2016 By admin

London, 17 April 2016 – Freeline Therapeutics (“Freeline”), a biopharmaceutical company focused on the development of gene therapies for bleeding and other debilitating disorders, today announced the acquisition of...

More >

Freeline is hiring

26th Feb 2016 By admin

Freeline is expanding its team. If you are excited about our mission, please see our careers sections for current vacancies. To see the latest vacancies please click here

More >

Freeline Therapeutics expands leadership team, names Dr Jan Thirkettle as Chief Development Officer and…

10th Jan 2016 By admin

London, 10 January 2016 – Freeline Therapeutics (“Freeline”), a biopharmaceutical company focused on the development of gene therapies for bleeding and other debilitating disorders, today announced that Jan Thirkettle,...

More >

Syncona and UCLB launch Freeline Therapeutics to develop gene therapies for bleeding disorders

10th Dec 2015 By admin

London, 10 December 2015 – Syncona LLP and UCL Business PLC (UCLB), the wholly-owned technology transfer company of UCL (University College London), announce the creation of the biopharmaceutical company,...

More >

Latest Events

We are currntly not attending any events, future events will be shown here.

Freeline Platform

Our proprietary and highly optimised platform is aiming to maximise clinical benefit for patients

Learn More >

Gene Therapy for Haemophilia

Gene therapy has the potential to transform people's lives by safely and continuously delivering clotting proteins to the blood

Learn More >

Freeline careers

Find out more about life at Freeline and current vacancies in our careers section

Learn More >